<!doctype html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Shock (Cardiovascular Focus) - Clinical Study Note</title>
    <link rel="icon" type="image/png" sizes="48x48" href="/icons/favicon-48.png?v=20260301-logoexact1" />
    <link rel="icon" type="image/png" sizes="32x32" href="/icons/favicon-32.png?v=20260301-logoexact1" />
    <link rel="icon" type="image/png" sizes="16x16" href="/icons/favicon-16.png?v=20260301-logoexact1" />
    <link rel="apple-touch-icon" sizes="180x180" href="/icons/favicon-180.png?v=20260301-logoexact1" />
    <style>
      :root {
        --bg: #f8fbff;
        --surface: #ffffff;
        --ink: #132841;
        --muted: #556b84;
        --line: #d7e4f0;
        --brand: #8a260f;
        --brand-soft: #fff2ed;
        --teal-soft: #eefaf6;
        --warn-soft: #fff7e8;
        --danger-soft: #fff0f0;
      }

      * {
        box-sizing: border-box;
      }

      body {
        margin: 0;
        font-family: "Segoe UI", Tahoma, Arial, sans-serif;
        color: var(--ink);
        background:
          radial-gradient(circle at 84% 8%, #ffdccc 0%, transparent 31%),
          radial-gradient(circle at 10% 20%, #e4f4ff 0%, transparent 24%),
          var(--bg);
      }

      .wrap {
        width: min(1240px, 94vw);
        margin: 22px auto 34px;
        display: grid;
        grid-template-columns: 290px 1fr;
        gap: 16px;
      }

      .panel {
        background: var(--surface);
        border: 1px solid var(--line);
        border-radius: 16px;
        box-shadow: 0 10px 24px rgba(13, 34, 62, 0.06);
      }

      .toc {
        position: sticky;
        top: 16px;
        max-height: calc(100dvh - 32px);
        overflow: auto;
        padding: 14px;
      }

      .toc h2 {
        margin: 0 0 10px;
        color: var(--brand);
        font-size: 1rem;
      }

      .toc a {
        display: block;
        text-decoration: none;
        color: #36506c;
        border-radius: 8px;
        padding: 7px 9px;
        font-size: 13px;
      }

      .toc a:hover {
        background: #fff5ef;
        color: #702010;
      }

      .content {
        padding: 0 0 18px;
      }

      .hero {
        padding: 20px;
        border-bottom: 1px solid var(--line);
        background: linear-gradient(160deg, #ffffff 0%, #fff3ed 56%, #eefaf6 100%);
      }

      .eyebrow {
        display: inline-flex;
        align-items: center;
        min-height: 28px;
        padding: 5px 12px;
        border-radius: 999px;
        background: var(--brand-soft);
        color: #8a260f;
        font-size: 12px;
        font-weight: 700;
        margin-bottom: 10px;
      }

      h1 {
        margin: 0;
        color: #6c1e0d;
        font-size: clamp(1.42rem, 2.4vw, 2.04rem);
      }

      .subtitle {
        margin: 8px 0 0;
        color: var(--muted);
        line-height: 1.55;
      }

      .hero-layout {
        margin-top: 14px;
        display: grid;
        grid-template-columns: 1.35fr 0.95fr;
        gap: 12px;
      }

      .hero-grid {
        display: grid;
        grid-template-columns: repeat(4, minmax(0, 1fr));
        gap: 10px;
      }

      .metric {
        border: 1px solid #f0d6cc;
        border-radius: 12px;
        background: #fff;
        padding: 10px;
      }

      .metric .k {
        font-size: 11px;
        color: #7d655d;
        margin-bottom: 6px;
        text-transform: uppercase;
        letter-spacing: 0.3px;
      }

      .metric .v {
        font-size: 14px;
        color: #6c1e0d;
        font-weight: 700;
      }

      .hero-visual {
        border: 1px solid #efd6cb;
        border-radius: 14px;
        background: #fff;
        padding: 10px;
        display: grid;
        gap: 8px;
      }

      .hero-visual h3 {
        margin: 0;
        font-size: 0.95rem;
        color: #6c1e0d;
      }

      .hero-visual p {
        margin: 0;
        font-size: 0.84rem;
        color: #5d758c;
      }

      .hero-visual svg {
        width: 100%;
        height: auto;
        display: block;
      }

      .section {
        padding: 16px 20px;
        border-bottom: 1px solid #edf3fb;
      }

      .section:last-child {
        border-bottom: none;
      }

      .section h2 {
        margin: 0 0 10px;
        color: #6c1e0d;
        font-size: 1.16rem;
      }

      .section p {
        margin: 0;
        color: #314860;
        line-height: 1.56;
      }

      .stack {
        margin-top: 10px;
        display: grid;
        gap: 10px;
      }

      .grid-2 {
        display: grid;
        grid-template-columns: repeat(2, minmax(0, 1fr));
        gap: 10px;
      }

      .grid-3 {
        display: grid;
        grid-template-columns: repeat(3, minmax(0, 1fr));
        gap: 10px;
      }

      .box {
        border: 1px solid var(--line);
        border-radius: 12px;
        padding: 11px 12px;
        background: #fff;
      }

      .box h3 {
        margin: 0 0 7px;
        font-size: 0.97rem;
        color: #1f4061;
      }

      .box p {
        margin: 0;
      }

      .box ul {
        margin: 0 0 0 17px;
        padding: 0;
      }

      .box li {
        margin: 4px 0;
        color: #304860;
      }

      .table {
        margin-top: 8px;
        width: 100%;
        border-collapse: collapse;
        border-radius: 12px;
        border: 1px solid var(--line);
        overflow: hidden;
      }

      .table th,
      .table td {
        padding: 10px;
        text-align: left;
        font-size: 14px;
        border-bottom: 1px solid #e8eff8;
        vertical-align: top;
      }

      .table th {
        background: #fff4ef;
        color: #6c1e0d;
      }

      .table tr:last-child td {
        border-bottom: none;
      }

      .chips {
        margin-top: 8px;
        display: flex;
        gap: 8px;
        flex-wrap: wrap;
      }

      .chip {
        display: inline-flex;
        align-items: center;
        min-height: 30px;
        padding: 4px 10px;
        border-radius: 999px;
        border: 1px solid #d8e4f2;
        background: #f8fbff;
        color: #254764;
        font-size: 13px;
        font-weight: 600;
      }

      .callout {
        margin-top: 10px;
        border-left: 4px solid #0f766e;
        border-radius: 10px;
        background: var(--teal-soft);
        color: #175358;
        padding: 10px 12px;
      }

      .callout.warn {
        border-left-color: #b66a00;
        background: var(--warn-soft);
        color: #7c5b1d;
      }

      .callout.alert {
        border-left-color: #b91c1c;
        background: var(--danger-soft);
        color: #6d2222;
      }

      .flow {
        margin-top: 10px;
        display: grid;
        gap: 9px;
      }

      .step {
        border: 1px solid #d5e3f4;
        border-radius: 12px;
        padding: 10px 11px;
        background: #f9fcff;
      }

      .step strong {
        color: #6c1e0d;
      }

      .arrow {
        width: 30px;
        height: 30px;
        margin: 0 auto;
        border-radius: 999px;
        border: 1px solid #c9d8ec;
        background: #f6fbff;
        color: #456887;
        font-weight: 900;
        display: grid;
        place-items: center;
        line-height: 1;
      }

      .diagram-card {
        margin-top: 10px;
        border: 1px solid #d8e4f2;
        border-radius: 12px;
        background: #fbfdff;
        padding: 11px;
      }

      .diagram-title {
        margin: 0 0 8px;
        font-size: 0.9rem;
        color: #1d3f62;
        font-weight: 700;
      }

      .refs a {
        color: #145aa9;
        text-decoration: none;
        word-break: break-word;
      }

      .refs a:hover {
        text-decoration: underline;
      }

      @media (max-width: 1040px) {
        .wrap {
          grid-template-columns: 1fr;
        }

        .toc {
          position: static;
          max-height: none;
        }

        .hero-layout {
          grid-template-columns: 1fr;
        }

        .hero-grid {
          grid-template-columns: repeat(2, minmax(0, 1fr));
        }
      }

      @media (max-width: 760px) {
        .grid-2,
        .grid-3,
        .hero-grid {
          grid-template-columns: 1fr;
        }
      }
    </style>
  </head>
  <body>
    <div class="wrap">
      <aside class="panel toc">
        <h2>On This Page</h2>
        <a href="#what-is-shock">1. What Is Shock?</a>
        <a href="#types-of-shock">2. Types of Shock</a>
        <a href="#cardiogenic-shock">3. Cardiogenic Shock</a>
        <a href="#vasopressors-and-inotropes">4. Vasopressors and Inotropes</a>
        <a href="#cardiogenic-shock-protocol">5. Cardiogenic Shock Protocol</a>
        <a href="#hypovolemic-shock">6. Hypovolemic Shock</a>
        <a href="#septic-shock">7. Septic Shock</a>
        <a href="#obstructive-shock">8. Obstructive Shock</a>
        <a href="#management-recap-drill">Recap Drill</a>
        <a href="#exam-traps">9. Common Exam Traps</a>
        <a href="#quick-revision">10. Quick Revision Summary</a>
      </aside>

      <article class="panel content">
        <header class="hero">
          <span class="eyebrow">Cardiovascular Disorders</span>
          <h1>Shock (Cardiovascular Focus)</h1>
          <p class="subtitle">
            Clinical overview and exam mastery guide for cardiogenic and obstructive shock,
            with high-yield vasopressor/inotrope selection and protocol sequencing.
          </p>

          <div class="hero-layout">
            <div class="hero-grid">
              <div class="metric">
                <div class="k">Core Problem</div>
                <div class="v">Tissue hypoperfusion</div>
              </div>
              <div class="metric">
                <div class="k">Cardiogenic Driver</div>
                <div class="v">Pump failure (often MI)</div>
              </div>
              <div class="metric">
                <div class="k">First-Line Pressor</div>
                <div class="v">Norepinephrine</div>
              </div>
              <div class="metric">
                <div class="k">Definitive Principle</div>
                <div class="v">Treat the cause</div>
              </div>
            </div>

            <div class="hero-visual">
              <h3>Shock Decision Framework</h3>
              <svg viewBox="0 0 500 220" role="img" aria-label="Shock overview diagram">
                <rect x="0" y="0" width="500" height="220" rx="14" fill="#fbfdff" />
                <rect x="20" y="30" width="220" height="72" rx="10" fill="#fff3ee" stroke="#f0d8cd" />
                <text x="40" y="55" fill="#6c1e0d" font-size="13" font-weight="700">Cardiogenic shock</text>
                <text x="40" y="73" fill="#7f655d" font-size="12">Pump failure -> low CO</text>
                <text x="40" y="89" fill="#7f655d" font-size="12">Pressor/inotrope plus reperfusion</text>

                <rect x="260" y="30" width="220" height="72" rx="10" fill="#fff1f1" stroke="#f2cbcb" />
                <text x="280" y="55" fill="#8b1a1a" font-size="13" font-weight="700">Obstructive shock</text>
                <text x="280" y="73" fill="#8d5959" font-size="12">PE/tamponade/pneumothorax</text>
                <text x="280" y="89" fill="#8d5959" font-size="12">Requires mechanical correction</text>

                <rect x="20" y="128" width="458" height="68" rx="10" fill="#ffffff" stroke="#d8e4f2" />
                <text x="249" y="154" text-anchor="middle" font-size="13" fill="#2a4963" font-weight="700">
                  Hemodynamic support is a bridge, not final treatment
                </text>
                <text x="249" y="172" text-anchor="middle" font-size="12" fill="#45637e">
                  Shock survival depends on rapid identification and reversal of the cause
                </text>
              </svg>
              <p>Drug choice and source-control timing determine outcomes.</p>
            </div>
          </div>
        </header>

        <section class="section" id="what-is-shock">
          <h2>1. What Is Shock?</h2>
          <p>
            Shock is life-threatening inadequate tissue perfusion causing organ dysfunction.
            The core defect is insufficient oxygen delivery to cells.
          </p>
        </section>

        <section class="section" id="types-of-shock">
          <h2>2. Types of Shock (High-Yield Classification)</h2>
          <div class="grid-2">
            <div class="box">
              <ul>
                <li>Cardiogenic shock</li>
                <li>Hypovolemic shock</li>
                <li>Distributive shock: septic, anaphylactic</li>
              </ul>
            </div>
            <div class="box">
              <ul>
                <li>Obstructive shock</li>
                <li>Cardiovascular emphasis: cardiogenic and obstructive phenotypes</li>
              </ul>
            </div>
          </div>
        </section>

        <section class="section" id="cardiogenic-shock">
          <h2>3. Cardiogenic Shock</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Pathophysiology</h3>
              <ul>
                <li>Severe pump failure with low cardiac output</li>
                <li>Hypotension and tissue hypoperfusion</li>
                <li>Most common trigger: acute MI</li>
              </ul>
            </div>
            <div class="box">
              <h3>Clinical Features</h3>
              <ul>
                <li>Hypotension</li>
                <li>Cool extremities</li>
                <li>Elevated JVP</li>
                <li>Pulmonary edema</li>
              </ul>
            </div>
          </div>
          <div class="callout">
            Goals: improve cardiac output, maintain perfusion pressure, and rapidly treat the underlying cause.
          </div>
        </section>

        <section class="section" id="vasopressors-and-inotropes">
          <h2>4. Vasopressors and Inotropes</h2>
          <table class="table">
            <thead>
              <tr>
                <th>Drug</th>
                <th>MOA</th>
                <th>Major Side Effects</th>
                <th>Use / Contraindications</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>Norepinephrine</td>
                <td>Alpha-1 vasoconstriction with beta-1 support of contractility</td>
                <td>Arrhythmias, peripheral ischemia</td>
                <td>First-line vasopressor in most shock states (including hypotensive cardiogenic shock)</td>
              </tr>
              <tr>
                <td>Dobutamine</td>
                <td>Beta-1 inotropy increases contractility and cardiac output</td>
                <td>Tachycardia, hypotension</td>
                <td>Useful for low-output states when BP is adequate or pressor-supported</td>
              </tr>
              <tr>
                <td>Dopamine</td>
                <td>Dose-dependent dopaminergic/beta/alpha effects</td>
                <td>Arrhythmias, tachycardia</td>
                <td>Less preferred due to rhythm risk profile</td>
              </tr>
              <tr>
                <td>Epinephrine</td>
                <td>Mixed alpha and beta agonism</td>
                <td>Arrhythmias, lactic rise, ischemia risk</td>
                <td>Key for anaphylactic shock and selected refractory shock scenarios</td>
              </tr>
            </tbody>
          </table>
        </section>

        <section class="section" id="cardiogenic-shock-protocol">
          <h2>5. Cardiogenic Shock Protocol</h2>
          <div class="flow">
            <div class="step"><strong>1:</strong> immediate cause treatment (e.g., MI to PCI/revascularization).</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>2:</strong> start norepinephrine if hypotensive.</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>3:</strong> add dobutamine if low output persists.</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>4:</strong> evaluate mechanical support (IABP/ECMO) when refractory.</div>
          </div>
        </section>

        <section class="section" id="hypovolemic-shock">
          <h2>6. Hypovolemic Shock</h2>
          <p>
            Common causes include blood loss and severe dehydration. Primary treatment is
            volume restoration with IV fluids and blood products when indicated.
          </p>
          <div class="callout warn">
            Vasopressors are secondary and should generally follow adequate volume resuscitation.
          </div>
        </section>

        <section class="section" id="septic-shock">
          <h2>7. Septic Shock (Brief Overview)</h2>
          <p>
            Septic shock features infection-driven vasodilation and circulatory failure.
            Initial management: fluids plus norepinephrine; vasopressin may be added in refractory cases.
          </p>
        </section>

        <section class="section" id="obstructive-shock">
          <h2>8. Obstructive Shock</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Examples</h3>
              <ul>
                <li>Massive pulmonary embolism</li>
                <li>Cardiac tamponade</li>
                <li>Tension pneumothorax</li>
              </ul>
            </div>
            <div class="box">
              <h3>Definitive Treatment</h3>
              <ul>
                <li>Remove the obstruction</li>
                <li>Thrombolysis/embolectomy for massive PE (selected patients)</li>
                <li>Pericardiocentesis for tamponade</li>
              </ul>
            </div>
          </div>
          <div class="callout alert">
            Drug support alone is not definitive in obstructive shock.
          </div>
        </section>

        <section class="section" id="management-recap-drill">
          <h2>Management Recap Drill</h2>
          <div class="flow">
            <div class="step"><strong>Cardiogenic:</strong> treat cause, start norepinephrine if hypotensive, add dobutamine for low output.</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Hypovolemic:</strong> fluids/blood first.</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Septic:</strong> fluids plus norepinephrine.</div>
            <div class="arrow" aria-hidden="true">&#8595;</div>
            <div class="step"><strong>Obstructive:</strong> mechanically relieve obstruction.</div>
          </div>

          <div class="diagram-card">
            <p class="diagram-title">Visual Algorithm Placeholder</p>
            <p>
              [Insert Shock Type Differentiation and Vasopressor Selection Flowchart Here During UI Integration]
            </p>
          </div>
        </section>

        <section class="section refs">
          <h2>Guideline References (Management)</h2>
          <div class="grid-2">
            <div class="box">
              <h3>AHA Cardiogenic Shock Guidance</h3>
              <a href="https://www.ahajournals.org" target="_blank" rel="noopener">
                https://www.ahajournals.org
              </a>
            </div>
            <div class="box">
              <h3>Surviving Sepsis Campaign</h3>
              <a href="https://www.sccm.org/SurvivingSepsisCampaign/Guidelines" target="_blank" rel="noopener">
                https://www.sccm.org/SurvivingSepsisCampaign/Guidelines
              </a>
            </div>
          </div>
        </section>

        <section class="section" id="exam-traps">
          <h2>9. Common Exam Traps</h2>
          <div class="stack">
            <div class="callout alert">Norepinephrine is first-line vasopressor in most shock states.</div>
            <div class="callout alert">Dobutamine improves contractility but can reduce blood pressure.</div>
            <div class="callout alert">Definitive shock care requires source/cause correction.</div>
            <div class="callout alert">Hypovolemia usually requires fluids before pressors.</div>
            <div class="callout alert">Obstructive shock needs mechanical correction.</div>
          </div>
        </section>

        <section class="section" id="quick-revision">
          <h2>10. Quick Revision Summary</h2>
          <div class="grid-2">
            <div class="box">
              <h3>Must Remember</h3>
              <ul>
                <li>Shock is systemic tissue hypoperfusion</li>
                <li>Cardiogenic shock is pump failure</li>
                <li>Norepinephrine is core first-line pressor</li>
                <li>Dobutamine is inotrope support for low output</li>
                <li>Fixing the cause is mandatory</li>
              </ul>
            </div>
            <div class="box">
              <h3>Practice Questions Placeholder</h3>
              <ul>
                <li>Topic: Shock</li>
                <li>
                  Subtopics: cardiogenic shock, vasopressors, inotropes, septic shock, obstructive shock
                </li>
              </ul>
            </div>
          </div>
        </section>
      </article>
    </div>
  </body>
</html>
